Akari Therapeutics PLC (AKTX)

1.38 0.00 (0.00%) USD  |  NASDAQ  |  Jan 07, 16:00
1.17 -0.21 (-15.22%) After-Hours: 18:40
More

Akari Therapeutics Cash and Short Term Investments (Quarterly): 2.246M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
DBV Technologies SA 46.44M
Ascendis Pharma AS 698.64M
Cellectis SA 260.89M
Adaptimmune Therapeutics PLC 186.09M
Biodexa Pharmaceuticals PLC 6.394M